Targets for molecular therapy of skin cancer

Cheryl L Green1, Paul A Khavari

  • 1Program in Epithelial Biology, Stanford University School of Medicine, 269 Campus Drive, Room 2145, Stanford, CA 94305, USA.

Insights

Skin cancers like basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are common. Gene alterations in these cancers offer new therapeutic targets by affecting key cellular pathways, paving the way for novel treatments.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and malignant melanoma (MM) are the most common skin cancers in the US.
  • Recent research has identified specific genetic alterations in these neoplasms.

Purpose of the Study:

  • To explore the role of identified genetic alterations in the development of skin cancers.
  • To identify potential therapeutic targets based on these genetic alterations.

Main Methods:

  • Analysis of genetic alterations in skin cancer cells.
  • Investigation of the impact of these alterations on cellular proliferation and viability pathways.

Main Results:

  • Identified alterations in conserved regulators of cellular proliferation and viability.
  • Highlighted the involvement of Sonic Hedgehog, Ras/Raf, ARF/p53, p16(INK4A)/CDK4/Rb, and NF-kappaB pathways.

Conclusions:

  • Specific gene alterations in skin cancers provide novel therapeutic targets.
  • Targeting these altered proteins may offer promising new treatment strategies for human skin cancers.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...